Dawn L. Hershman, MD, Herbert Irving Comprehensive Cancer Center at Columbia University
Advertisement
Articles by Dawn L. Hershman, MD, Herbert Irving Comprehensive Cancer Center at Columbia University
Advertisement
Latest Updated Articles
Rapid Readouts: Updated Results From KX-ORAX-001 StudyPublished: December 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5